Welcome to BAC
BAC is an established biotech company providing the life science industry with unparalleled protein purification technologies for drug manufacture and research. These CaptureSelect® products possess a combination of unique properties such as stability, affinity and selectivity, which provide competitive benefits in terms of reduced cost of purification, higher quality product, and increased flexibility in the purification process.
With the rise in biological therapeutics, the purification of protein is becoming an increasingly critical step throughout the life science industry. BAC’s products apply across the industry, from early-stage and academic research to full scale global manufacturing of pharmaceuticals.
Download the latest version of our company presentation including our product pipeline. 
BAC News and Events
BAC BV expands alliance with Octapharma Group for the purification of recombinant proteins More >
BAC expands collaboration with GE Healthcare with launch of KappaSelect More >
Meet BAC at the upcoming Antibody Development & Production conference (3-5 March - Carlsbad, CA - Booth #209). Click on the banner for a 25% discount on registration.
CaptureSelect products are created by BAC’s proprietary technology based on the single domain antibodies found in Camelidae, specifically llamas. CaptureSelect affinity ligands can be selected and developed for almost any purification target and are efficiently produced in-house using Saccharomyces cerevisiae. BAC’s has provided a custom ligand design service to pharmaceutical and biotech companies since 2003. CaptureSelect ligands are also available as off-the-shelf products for commercial-scale processes or for bench research. For further information on CaptureSelect technology visit our dedicated product and technology site www.captureselect.com.




